2016 Patient Advocate Hot Topic Reports
The following reports were submitted by Erin Rowley – 2016 Advocate Triple -Negative Trial: Carboplatin vs. Docetaxel in Women with Metastatic Tumors That Have “Silenced ” BRCA1 Gene Study of the Benefit of Adding Bisphosphonate to Treatment for Early-Stage Hormone Receptor-Positive Breast Cancer. Erin Rowley 2016 Advocate